Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcranial Pulse Stimulation (TPS) in Post-COVID-19
Sponsor: Medical University of Vienna
Summary
The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
102
Start Date
2024-01-08
Completion Date
2027-01
Last Updated
2025-12-23
Healthy Volunteers
No
Conditions
Interventions
Transcranial pulse stimulation Verum
Participants are slated to undergo a total of five TPS sessions over a 10-day interval. Each stimulation session will endure approximately 30 minutes and will be administered once daily.
Transcranial pulse stimulation Sham
Placebo treatment will be performed using the same medical device, handpiece and treatment paradigm as in the verum treatment with one difference: the standoff device at the end of the handpiece. This device is designed to replicate the appearance, feel, and sound of the verum system, while omitting the transmission of any pulses.
Locations (1)
Medical University of Vienna
Vienna, Vienna, Austria